EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

Jiaqi Li, Justin Yi Shen Lim, Jie Qing Eu iD, Andrew Kieran Ming Hui Chan, Boon Cher Goh, Lingzhi Wang, Andrea Li-Ann Wong

Antioxidants & Redox Signaling · 2024

DOI: 10.1089/ars.2023.0445 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, 2024. Verfasst von Jiaqi Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Neoplasms, Antineoplastic Agents, Oxidative Stress. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 210 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Significance: Reactive oxygen species (ROS) are generated during mitochondrial oxidative metabolism, and are tightly controlled through homeostatic mechanisms to maintain intracellular redox, regulating growth and proliferation in healthy cells. However, ROS production is perturbed in cancers where abnormal accumulation of ROS leads to oxidative stress and genomic instability, triggering oncogenic signaling pathways on one hand, while increasing oxidative damage and triggering ROS-dependent death signaling on the other. Recent Advances: Our review illuminates how critical interactions between ROS and oncogenic signaling, the tumor microenvironment, and DNA damage response (DDR) pathways have led to interest in ROS modulation as a means of enhancing existing anticancer strategies and developing new therapeutic opportunities. Critical Issues: ROS equilibrium exists via a delicate balance of pro-oxidant and antioxidant species within cells. “Antioxidant” approaches have been explored mainly in the form of chemoprevention, but there is insufficient evidence to advocate its routine application. More progress has been made via the “pro-oxidant” approach of targeting cancer vulnerabilities and inducing oxidative stress. Various therapeutic modalities have employed this approach, including direct ROS-inducing agents, chemotherapy, targeted therapies, DDR therapies, radiotherapy, and immunotherapy. Finally, emerging delivery systems such as “nanosensitizers” as radiotherapy enhancers are currently in development. Future Directions: While approaches designed to induce ROS have shown considerable promise in selectively targeting cancer cells and dealing with resistance to conventional therapies, most are still in early phases of development and challenges remain. Further research should endeavor to refine treatment strategies, optimize drug combinations, and identify predictive biomarkers of ROS-based cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesNeoplasmsAntineoplastic AgentsOxidative StressHumansAnimalsAntioxidantsTumor MicroenvironmentSignal TransductionDNA Damage

Stichwörter der Autor:innen

ROS-inducing drugscancer treatmentoxidative stressreactive oxygen species

Substanzen

Reactive Oxygen SpeciesAntineoplastic AgentsAntioxidants

Autor:innen und Institutionen

  • Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Tan Tock Seng Hospital, Singapore, Singapore.
  • Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Somerset NHS Foundation Trust, Somerset, United Kingdom.
  • Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

ORCID-Profile: Jie Qing Eu

Zitieren

APA

Li, J., Lim, J. Y. S., Eu, J. Q., Chan, A. K. M. H., Goh, B. C., Wang, L., & Wong, A. L. (2024). Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2023.0445

Vancouver

Li J, Lim JYS, Eu JQ, Chan AKMH, Goh BC, Wang L, et al. Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies. Antioxidants & Redox Signaling. 2024. doi:10.1089/ars.2023.0445

BibTeX
@article{Li2024,
  author = {Li, Jiaqi and Lim, Justin Yi Shen and Eu, Jie Qing and Chan, Andrew Kieran Ming Hui and Goh, Boon Cher and Wang, Lingzhi and Wong, Andrea Li-Ann},
  title = {Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies},
  journal = {Antioxidants & Redox Signaling},
  year = {2024},
  doi = {10.1089/ars.2023.0445}
}
Kostenlos starten →